Publications
Detailed Information
Topical tacrolimus 0.03% for maintenance therapy in steroid-dependent, recurrent phlyctenular keratoconjunctivitis
Cited 5 time in
Web of Science
Cited 6 time in Scopus
- Authors
- Issue Date
- 2018-01
- Publisher
- Lippincott Williams & Wilkins Ltd.
- Citation
- Cornea, Vol.37 No.2, pp.168-171
- Abstract
- Purpose: To evaluate the efficacy of topical tacrolimus 0.03% as steroid-free maintenance therapy in young patients with severe, recurrent phlyctenular keratoconjunctivitis (PKC). Methods: The medical records of 6 eyes of 5 patients (4 children and 1 young adult) with recurrent, steroid-dependent PKC were reviewed. The patients were treated with combined application of topical steroids and tacrolimus 0.03% in the active phase and maintained on topical tacrolimus alone after remission. Results: The clinical signs, symptoms, and visual acuities resolved in all patients after 25.2 +/- 16.9 days of combined treatment with steroids and tacrolimus. After disease remission, the patients were maintained on topical tacrolimus 0.03% once daily alone for 8.4 +/- 4.7 months, and no recurrence occurred during 10.6 +/- 1.9 months of follow-up. Tacrolimus was successfully discontinued in 2 patients without further recurrence. There were no ocular side effects related to the use of topical tacrolimus. Conclusions: Topical tacrolimus 0.03% was effective in maintaining long-term remission in patients with recurrent, steroid-dependent PKC.
- ISSN
- 0277-3740
- Files in This Item:
- There are no files associated with this item.
- Appears in Collections:
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.